KEREOS, INC

Profile

Company Names

KEREOS, INC
KEREOS INC

Addresses

4041 FOREST PARK AVE, ST. LOUIS, MO 63108

4041 FOREST PARK AVENUE, ST. LOUIS, MO 63108

4041 FOREST PARK AVE, ST LOUIS, MO 63108

Phone Numbers

314-633-1879

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$7,689,954.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2011-09-23 
$1,127,730.00 
$1,127,730.00 
$0.00 
Equity 
2
2010-04-23 
$5,675,098.00 
$6,217,618.00 
$542,520.00 
Equity 
1
2009-06-15 
$887,126.00 
$887,426.00 
$300.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PHILLIP 
M 
BUCKLER 
EXECUTIVE OFFICER
KEREOS INC
PHILLIP 
M. 
BUCKLER 
EXECUTIVE OFFICER
KEREOS, INC
GREGORY 
R. 
JOHNSON, PH. D. 
DIRECTOR
KEREOS, INC
GREGORY 
R 
JOHNSON, PH.D. 
DIRECTOR
KEREOS INC
GREGORY 
R. 
JOHNSON, PH.D. 
DIRECTOR
KEREOS, INC
MICHAEL 
D. 
LOBERG, PH. D. 
DIRECTOR
KEREOS, INC
MICHAEL 
 
LOBERG, PH.D. 
DIRECTOR
KEREOS INC   |  KEREOS, INC
JOHN 
 
RICE, PH. D. 
DIRECTOR
KEREOS, INC
JOHN 
 
RICE, PH.D. 
DIRECTOR
KEREOS, INC
JOHN 
M 
RICE, PH.D. 
DIRECTOR
KEREOS INC
FRED 
 
SCHWARTZER 
DIRECTOR
KEREOS INC
FRED 
 
SCHWARZER 
DIRECTOR
INVIRAGEN, INC.   |  KEREOS, INC   |  HEALTH FIDELITY, INC.   |  GREAT LAKES PHARMACEUTICALS, INC.   |  MIRABILIS MEDICA INC   |  MIRABILIS MEDICA, INC.   |  MULTIVALENT BIOTHERAPIES, INC.
FRED 
A. 
SCHWARZER, J.D. 
DIRECTOR
KEREOS, INC
STEPHEN 
 
SNOWDY 
DIRECTOR
CALOSYN PHARMA, INC.   |  KEREOS, INC   |  ABBY MED, LLC   |  CYTRX CORP   |  MULTIVALENT BIOTHERAPIES, INC.
STEPHEN 
 
SNOWDY, PH.D. 
DIRECTOR
KEREOS INC
GARY 
 
STEVENSON 
DIRECTOR
BIOSURFACE ENGINEERING TECHNOLOGIES INC   |  KEREOS, INC   |  RESTORE MEDICAL SOLUTIONS, INC.   |  SPINAL RESTORATION INC   |  HAPTEN SCIENCES, INC.   |  CAMPLEX, INC.   |  ORTHO KINEMATICS, INC.   |  CROSSROADS EXTREMITY SYSTEMS, LLC   |  SITE SAVER, INC.   |  FOCAL POINT PHARMACEUTICALS, INC.   |  STATERA SPINE, INC.   |  CRES HOLDINGS, INC.   |  CAST21, INC.
SAMUEL 
 
WICKLINE, M.D. 
DIRECTOR
KEREOS INC
SAMUEL 
A. 
WICKLINE, M.D. 
DIRECTOR
KEREOS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-01-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-23 
2010-05-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-23 
2009-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#